Twitter and become a fan on Facebook.
TheStreet's biotech columnist offers his own report card on biotech stocks.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Trade-Ideas LLC identified Ampio Pharmaceuticals (AMPE) as a weak on high relative volume candidate
Ampio Pharmaceuticals (AMPE) shares are up over 10% after the company received Special Protocol Assessment from the FDA.